Sherry E. Courtney
Director of Clinical Research, Neonatology
Also affiliated: University of Toledo Medical Center (1999); Women & Children's Hospital of Buffalo (2006); Mercy St. Vincent Medical Center (2002); Arkansas Children's Hospital (2014–2026); Northwell Health (2003–2014); Beth Israel Deaconess Medical Center (2018); Lucile Packard Children's Hospital (2021); Children's Hospital of Philadelphia (2006); Harvard University (2018); University of Louisville (2020–2021); Johns Hopkins University (2020); Wright State University (1984–1992); University of Washington (2020); Washington University in St. Louis (2006); University of Arkansas Medical Center (2024); Long Island Jewish Medical Center (2003–2006); Cooper University Hospital (1998–2003); Stony Brook University Hospital (2009–2012); Centre Hospitalier Universitaire Sainte-Justine (2021); University of Florida (2020); University of Illinois Chicago (1991–1992); Virtua Voorhees Hospital (2001); Johns Hopkins All Children's Hospital (2020); Mercy Children's Hospital (2002); Stony Brook Medicine (2010–2013); Dayton Children's Hospital (1987–1995); Children's Hospital of Pittsburgh (1992); Schneider Children's Hospital (2002–2014); Arkansas Children's Research Institute (2021–2025); Rowan University (2002); Stony Brook University (2011–2013); University of Pennsylvania (2006); University of Toledo (2008); The University of Texas Health Science Center at Houston (2024); Stanford University (2021)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sherry E. Courtney's research focuses on respiratory support and interventions for premature infants. Her work has investigated various mechanical ventilation strategies, including high-frequency oscillatory ventilation (HFOV) compared to conventional mechanical ventilation (CMV) in very-low-birth-weight infants. She has also examined the use of inhaled nitric oxide in this population and evaluated different devices for nasal continuous positive airway pressure (CPAP) delivery, assessing work of breathing and lung recruitment.
Courtney has also explored other therapeutic avenues for preterm infants, such as a randomized trial of erythropoietin for neuroprotection. Her publication history includes work on synthetic surfactant for respiratory distress syndrome and the definition of neonatal acute respiratory distress syndrome (ARDS). With an h-index of 31 and over 4,400 citations across 142 publications, she is recognized as a highly cited researcher and leads a research group at the University of Arkansas for Medical Sciences, collaborating with colleagues such as David N. Matlock and Billy R. Thomas.
Metrics
- h-index: 31
- Publications: 139
- Citations: 4,459
Positions
-
Director of Clinical Research, Neonatology 2012–presentUniversity of Arkansas for Medical Sciences Pediatrics Institutional directory
Selected Publications
-
Fetal magnetoencephalographic power spectral density and neurobehavioral correlation in fetal growth restriction (FGR) (2026)
-
A106-23 Association Between Genetic Variation in Corticotropin-releasing Hormone Receptor 1 (CRHR1) and Change in Respiratory Severity Score After Corticosteroid Treatment in Extremely Premature Infants (2026)
-
Positive end-expiratory pressure levels during resuscitation of preterm infants at birth (POLAR): study protocol for a randomised controlled trial (2026)
-
Fetal Magnetoencephalographic Power Spectral Density and Neurobehavioral Correlation in Intrauterine Growth Restriction (IUGR) (2026)
-
Can postnatal steroids or initial mode of respiratory support really impact lung function at adulthood in preterm survivors? (2025)
-
Partial waiver of consent to overcome translational science barriers in neonatal clinical research (2025)
-
Salivary cortisol is not associated with dexamethasone response in preterm infants with evolving bronchopulmonary dysplasia (2024)
-
Feasibility of synchronized high flow nasal cannula (2024)
-
Transcatheter patent ductus arteriosus closure in premature infants requiring high-frequency ventilation (2024)
-
Novel forms of ventilation in neonates: Neurally adjusted ventilatory assist and proportional assist ventilation (2024)
-
Effect of Early vs Late Inguinal Hernia Repair on Serious Adverse Event Rates in Preterm Infants (2024)
-
Neonatal high frequency ventilation: Current trends and future directions (2024)
-
The Diaphragmatic Initiated Ventilatory Assist (DIVA) trial: study protocol for a randomized controlled trial comparing rates of extubation failure in extremely premature infants undergoing extubation to non-invasive neurally adjusted ventilatory assist versus non-synchronized nasal intermittent positive pressure ventilation (2024)
-
Urine biomarkers of acute kidney injury and association with brain MRI abnormalities in neonatal hypoxic-ischemic encephalopathy (2024)
-
Tidal volume delivery during nasal intermittent positive pressure ventilation: infant cannula vs. nasal continuous positive airway pressure prongs (2023)
Grants & Funding
As listed on this researcher's institutional profile.
- A Phase 1b, Randomized, Blinded, Dose-Determined Study Evaluating the Safety and Tolerability Profile of Intervention with AT-100 (rhSP-D) in Preterm Neonates at High Risk for the Development of Bronchopulmonary Dysplasia (BPD) (IRB 273675) Airway Therapeutics, Inc.
- HEAL Study UAMS ACHRI Flow Through
- PENUT Trial Year 3 UAMS ACHRI Flow Through
- Developmental Impact of NICU Exposures (DINE) UAMS ACHRI Flow Through
- An Open-label, Multicenter, Randomized, Controlled Study in Spontaneously Breathing Preterm Neonates with Respiratory Distress Syndrome to Compare Two Procedures for Porcine Surfactant Administration (IRB 273485) Chiesi Farmaceutici S.p.A via Labcorp
- Trial of Late Surfactant-TOLSURF (ACHRI # 034548) UAMS ACHRI Flow Through
- Trial of Late Surfactant-TOLSURF (034348) UAMS ACHRI Flow Through
Collaboration Network
Top Collaborators
- Tidal volume transmission during non-synchronized nasal intermittent positive pressure ventilation via RAM® cannula
- Ventilatory Strategies in Infants with Established Severe Bronchopulmonary Dysplasia: A Multicenter Point Prevalence Study
- Effect of Transcutaneous Electrode Temperature on Accuracy and Precision of Carbon Dioxide and Oxygen Measurements in the Preterm Infants
- Work of Breathing in Premature Neonates: Noninvasive Neurally-Adjusted Ventilatory Assist versus Noninvasive Ventilation
- The Diaphragmatic Initiated Ventilatory Assist (DIVA) trial: study protocol for a randomized controlled trial comparing rates of extubation failure in extremely premature infants undergoing extubation to non-invasive neurally adjusted ventilatory assist versus non-synchronized nasal intermittent positive pressure ventilation
Showing 5 of 11 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Informed consent for a neonatal clinical trial: parental experiences and perspectives
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
Showing 5 of 9 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age
Showing 5 of 8 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age
Showing 5 of 8 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- The Randomized, Controlled Trial of Late Surfactant: Effects on Respiratory Outcomes at 1-Year Corrected Age
Showing 5 of 8 shared publications
- Tidal volume transmission during non-synchronized nasal intermittent positive pressure ventilation via RAM® cannula
- Effect of Transcutaneous Electrode Temperature on Accuracy and Precision of Carbon Dioxide and Oxygen Measurements in the Preterm Infants
- Effect of ventilator mode on patient‐ventilator synchrony and work of breathing in neonatal pigs
- Work of Breathing in Premature Neonates: Noninvasive Neurally-Adjusted Ventilatory Assist versus Noninvasive Ventilation
- Comparison of Work of Breathing Between Noninvasive Ventilation and Neurally Adjusted Ventilatory Assist in a Healthy and a Lung-Injured Piglet Model
Showing 5 of 8 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Informed consent for a neonatal clinical trial: parental experiences and perspectives
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
Showing 5 of 7 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Informed consent for a neonatal clinical trial: parental experiences and perspectives
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
Showing 5 of 7 shared publications
- The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity
- Clinical prediction models for bronchopulmonary dysplasia: a systematic review and external validation study
- Epidemiology of Neonatal Acute Respiratory Distress Syndrome: Prospective, Multicenter, International Cohort Study
- Lung ultrasound and neonatal ARDS: is Montreux closer to Berlin than to Kigali? – Authors' reply
- Neonatal high frequency ventilation: Current trends and future directions
Showing 5 of 6 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Showing 5 of 6 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Showing 5 of 6 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Showing 5 of 6 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Showing 5 of 6 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Showing 5 of 6 shared publications
- A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
- Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial
- Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
- Gestational age, sex, and time affect urine biomarker concentrations in extremely low gestational age neonates
- Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns
Showing 5 of 6 shared publications
Similar Researchers
Based on overlapping research topics